Muricholic Acid Species Regulation Networks: From Biosynthetic Pathways to Molecular Mechanisms

Bile acids (BAs) are pleiotropic signaling molecules. Muricholic acids (MCAs), a distinct BA subgroup with hydroxyl groups at C3, C6, and/or C7, exhibit structural diversity that underpins functional heterogeneity. This review summarizes MCA species and their derivatives, emphasizing metabolic pathway differences between rodents and humans. We explore gut microbiota-mediated MCA transformation and the associated regulatory networks. MCAs modulate key signaling receptors—farnesoid X receptor (FXR), Takeda G protein-coupled receptor 5 (TGR5), and peroxisome proliferator-activated receptor α (PPARα)—as well as pathways including the gut–liver axis, ceramide metabolism, cyclic guanosine monophosphate–protein kinase G–mechanistic target of rapamycin complex 1 (cGMP–PKG–mTORC1) signaling, and the hypothalamic–pituitary–gonadal (HPG) axis. These actions implicate MCAs in metabolic dysfunction-associated steatotic liver disease (MASLD), type 2 diabetes mellitus (T2DM), inflammatory bowel disease (IBD), central precocious puberty (CPP). Their potential as diagnostic, predictive, and prognostic biomarkers is also discussed. This synthesis provides a theoretical foundation for understanding MCA-driven disease mechanisms and developing novel therapeutic strategies.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-19
DOI
https://doi.org/10.3390/ijms272210428
Primary Topic
Drug Transport and Resistance Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Muricholic Acid Species Regulation Networks: From Biosynthetic Pathways to Molecular Mechanisms

魏丽慧, Guangzeng Zhou, Rong Rong, Yan Ni et al.
International Journal of Molecular Sciences
Drug Transport and Resistance Mechanisms
article

Muricholic Acid Species Regulation Networks: From Biosynthetic Pathways to Molecular Mechanisms

魏丽慧, Guangzeng Zhou, Rong Rong, Yan Ni, Mai Han
article en

Abstract

Bile acids (BAs) are pleiotropic signaling molecules. Muricholic acids (MCAs), a distinct BA subgroup with hydroxyl groups at C3, C6, and/or C7, exhibit structural diversity that underpins functional heterogeneity. This review summarizes MCA species and their derivatives, emphasizing metabolic pathway differences between rodents and humans. We explore gut microbiota-mediated MCA transformation and the associated regulatory networks. MCAs modulate key signaling receptors—farnesoid X receptor (FXR), Takeda G protein-coupled receptor 5 (TGR5), and peroxisome proliferator-activated receptor α (PPARα)—as well as pathways including the gut–liver axis, ceramide metabolism, cyclic guanosine monophosphate–protein kinase G–mechanistic target of rapamycin complex 1 (cGMP–PKG–mTORC1) signaling, and the hypothalamic–pituitary–gonadal (HPG) axis. These actions implicate MCAs in metabolic dysfunction-associated steatotic liver disease (MASLD), type 2 diabetes mellitus (T2DM), inflammatory bowel disease (IBD), central precocious puberty (CPP). Their potential as diagnostic, predictive, and prognostic biomarkers is also discussed. This synthesis provides a theoretical foundation for understanding MCA-driven disease mechanisms and developing novel therapeutic strategies.

International Journal of Molecular SciencesVol. 27(22)
Shandong University of Traditional Chinese Medicine (CN), Children's Hospital of Zhejiang University (CN), Zhejiang University (CN)
Drug Transport and Resistance Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon